Cytokinetics, Incorporated
US ˙ NasdaqGS ˙ US23282W6057

SecurityCYTK / Cytokinetics, Incorporated
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership14,150 shares
Latest Disclosed Value $ 762,544
Wolverine Trading, Llc ownership in CYTK / Cytokinetics, Incorporated

On November 14, 2025 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 14,150 shares of Cytokinetics, Incorporated (US:CYTK) valued at $777,684 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 18, 2025 disclosing 25,808 shares of Cytokinetics, Incorporated. This represents a change in shares of -45.17% during the quarter. The current value of the position is $1,000,546 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (CYTK) in the form of stock options. The firm currently holds call options representing 89,800 of underlying shares valued at $4,839,322 USD and put options representing 19,500 of underlying shares valued at $1,050,855 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CYTK / Cytokinetics, Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F CYTOKINETICS COM NEW 23282W605 14,150 -11,658 -45.17 763 -10.88 0.0005
2025-08-18 2025-06-30 13F CYTOKINETICS COM NEW 23282W605 25,808 12,742 97.52 856 51.60 0.0009
2025-05-15 2025-03-31 13F CYTOKINETICS COM NEW 23282W605 13,066 13,066 564 0.0007
2024-11-14 2024-09-30 13F CYTOKINETICS COM NEW 23282W605 0 -4,128 -100.00 0 -100.00
2024-08-14 2024-06-30 13F CYTOKINETICS COM NEW 23282W605 4,128 -5,560 -57.39 224 -67.16 0.0002
2024-05-15 2024-03-31 13F CYTOKINETICS COM NEW 23282W605 9,688 -626 -6.07 679 -21.14 0.0007
2024-02-14 2023-12-31 13F CYTOKINETICS COM NEW 23282W605 10,314 10,314 861 0.0009
2016-11-14 2016-09-30 13F CYTOKINETICS COM NEW 23282W605 0 -51 -100.00 0 -100.00 0.0000
2016-08-15 2016-06-30 13F CYTOKINETICS COM NEW 23282W605 51 51 0 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F CYTOKINETICS COM NEW Call 89,800 13.96 4,839 85.19 n/a n/a n/a
2025-08-18 2025-06-30 13F CYTOKINETICS COM NEW Call 78,800 -6.64 2,613 -28.31 n/a n/a n/a
2025-05-15 2025-03-31 13F CYTOKINETICS COM NEW Call 84,400 38.59 3,645 26.96 n/a n/a n/a
2025-02-14 2024-12-31 13F CYTOKINETICS COM NEW Call 60,900 15.12 2,871 3.72 n/a n/a n/a
2024-11-14 2024-09-30 13F CYTOKINETICS COM NEW Call 52,900 140.45 2,769 132.41 n/a n/a n/a
2024-08-14 2024-06-30 13F CYTOKINETICS COM NEW Call 22,000 30.95 1,192 1.19 n/a n/a n/a
2024-05-15 2024-03-31 13F CYTOKINETICS COM NEW Call 16,800 -75.26 1,178 -79.23 n/a n/a n/a
2024-02-14 2023-12-31 13F CYTOKINETICS COM NEW Call 67,900 5,669 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F CYTOKINETICS COM NEW Put 19,500 -45.53 1,051 -11.54 n/a n/a n/a
2025-08-18 2025-06-30 13F CYTOKINETICS COM NEW Put 35,800 41.50 1,187 8.70 n/a n/a n/a
2025-05-15 2025-03-31 13F CYTOKINETICS COM NEW Put 25,300 31.09 1,093 20.13 n/a n/a n/a
2025-02-14 2024-12-31 13F CYTOKINETICS COM NEW Put 19,300 -0.52 910 -10.44 n/a n/a n/a
2024-11-14 2024-09-30 13F CYTOKINETICS COM NEW Put 19,400 90.20 1,015 83.88 n/a n/a n/a
2024-08-14 2024-06-30 13F CYTOKINETICS COM NEW Put 10,200 -53.21 553 -63.87 n/a n/a n/a
2024-05-15 2024-03-31 13F CYTOKINETICS COM NEW Put 21,800 -39.78 1,528 -49.44 n/a n/a n/a
2024-02-14 2023-12-31 13F CYTOKINETICS COM NEW Put 36,200 3,022 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.